India has covered enough population with vaccine and infection, but protein vaccines should remain available on payment basis for elderly and those with comorbidities. IMAGE: A healthcare worker......
Vaccine makers in India have a limited stockpile of doses, even as COVID-19 threatens to rear its head this winter season, reports Sohini Das. IMAGE: A beneficiary is being inoculated with a......
The Drugs Controller General of India has approved the manufacture of this Sars-CoV-2 spike protein recombinant nano-particle vaccine for ‘examination, test, and analysis’,......
Prime Minister Narendra Modi on Saturday met Indian COVID-19 vaccine manufacturers who said his leadership was a key factor in India being able to administer 100 crore doses of the jabs in just......
Prime Minister Narendra Modi will meet seven Indian COVID-19 vaccine manufacturers on Saturday, a meeting that comes in the wake of the country achieving the landmark of administering 100 crore......
New Delhi-based pharmaceutical major Mankind Pharma is poised to take pole position in women’s health portfolio in the India Pharma Market (IPM) after completing the Rs 13,630 crore deal to......
In the midst of third wave of COVID-19, Finance Minister Nirmala Sitharaman has come up with an impactful Budget which is balanced, fiscally prudent and growth-oriented, the USA India Chamber of......
'We are going to be overwhelmed by the need for hospital beds. There are simply not enough beds in government hospitals.''We will need a large number of medical professionals and without the......
If we are to realise the full potential of biologics' ability to improve people's health, it is essential to encourage public policy and support R&D. IMAGE: It’s been evident for a decade......
Markets have extended losses and are trading near day's low with Nifty breaking the important 8,200 mark as participants remain cautious ahead of the RBI's bi-monthly monetary policy review due......